PMDA
- Application: Olumiant Initial Approval
- Local brand name: Olumiant Initial Approval
- Status: approved
🇯🇵 Baricitinib 4 MG in Japan
Baricitinib 4 MG (Baricitinib 4 MG) regulatory status in Japan.
Marketing authorisations
PMDA
- Application: Olumiant Partial Change Approval
- Local brand name: Olumiant Partial Change Approval
- Status: approved
Baricitinib 4 MG in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Baricitinib 4 MG approved in Japan?
Yes. PMDA has authorised it; PMDA has authorised it.
Who is the marketing authorisation holder for Baricitinib 4 MG in Japan?
University Hospital, Rouen is the originator. The local marketing authorisation holder may differ — check the official source linked above.